HB 1780
In CommitteeHouse
Doctor title/health provider
Promoting accurate communications between patients and health care providers.
This status may be delayed. See Action History below for the latest updates.
How does a bill become law?
- Introduced: The bill is filed and assigned a number.
- Committee: A subject-matter committee holds hearings, takes public testimony, and decides whether to advance the bill.
- Floor Vote: The full chamber (House or Senate) debates and votes on the bill.
- Opposite Chamber: The bill repeats the committee and floor vote process in the other chamber.
- Governor: The Governor reviews the bill and decides whether to sign or veto it.
- Signed: The bill has been signed into law.
AI Analysis
This bill prevents physician assistants and nurse practitioners from calling themselves 'doctor' when treating patients in clinical settings, to avoid confusion about their credentials. It aims to ensure transparency and help patients understand who is providing their care.
- Prohibits physician assistants from referring to themselves as 'doctor' in clinical settings — this is classified as unprofessional conduct under state law.
- Prohibits advanced registered nurse practitioners (ARNPs) and advanced practice registered nurses (APRNs) — including nurse practitioners — from using the title 'doctor' in clinical settings — also considered unprofessional conduct.
- Amends existing laws governing nurse and physician assistant titles to explicitly include these restrictions, reinforcing enforcement under the state’s professional discipline framework (Chapter 18.130 RCW).
- Adds a sunset clause — the ban on using 'doctor' for ARNPs/APRNs (Section 2) expires on June 30, 2027, unless extended by future legislation.
- The law banning 'doctor' use for physician assistants (Section 4) remains in effect permanently, with no expiration date.
Who is affected
- Physician assistants — Physician assistants (PAs) would be prohibited from using the title 'doctor' when interacting with patients in clinical settings, and must instead use their official titles (e.g., 'physician assistant' or 'PA'). This affects how they introduce themselves and how their credentials are presented to patients.
- Nurse practitioners and other advanced practice nurses — Advanced registered nurse practitioners (ARNPs) and advanced practice registered nurses (APRNs) — including nurse practitioners — would be prohibited from using the title 'doctor' in clinical settings, and must instead use titles like 'nurse practitioner' or 'ARNP'. This affects how they identify themselves during patient care.
- Patients receiving care in clinical settings — Patients may benefit from clearer understanding of their providers’ qualifications, reducing confusion about who is a physician versus other licensed clinicians. This could improve informed consent and trust in care decisions.
- Health care employers and institutions — Health care employers (hospitals, clinics, group practices) would need to update internal policies, signage, name badges, and electronic health records to ensure compliance with the new title restrictions.
Pro/Con Analysis
Stronger case for concerns
Potential Benefits (5)
Patients may experience improved clarity about provider credentials, reducing confusion between MD/DOs and advanced practice clinicians—potentially enhancing informed consent and trust, especially among older, less tech-savvy, or lower-literacy patients who may not distinguish between 'doctor' titles.
HealthcarePeopleRef: Sec. 1(1)(c), Sec. 2(2)(b), Sec. 3(2)(b), Sec. 4(5)By reducing misrepresentation risk, the bill may lower liability exposure for providers and institutions and improve patient safety by ensuring patients understand who is leading their care team—particularly important in high-risk scenarios like surgery or complex chronic disease management.
Public SafetyPeopleRef: Sec. 1(1)(d), Sec. 2(2)(b), Sec. 3(2)(b), Sec. 4(5)The bill may improve interprofessional communication by clarifying roles within care teams, reducing role ambiguity that can lead to miscommunication or duplicated work—especially valuable in team-based care models like FQHCs and integrated health systems.
HealthcarePeopleRef: Sec. 1(1)(a), Sec. 2(2)(b), Sec. 3(2)(b), Sec. 4(5)The bill may prompt renewed public education about healthcare provider roles, potentially increasing transparency about training pathways—though this benefit is speculative and depends on concurrent outreach efforts by boards and providers.
EducationLean peopleRef: Sec. 1(1)(b), Sec. 2(2)(b), Sec. 3(2)(b), Sec. 4(5)The bill’s stated goal of protecting patients from misrepresentation may foster a perception of greater accountability and ethical rigor in healthcare—though this is largely symbolic without evidence of widespread patient harm from current title usage.
Rights & LibertiesLean peopleRef: Sec. 1(1)(d), Sec. 2(2)(b), Sec. 3(2)(b), Sec. 4(5)
Potential Concerns (5)
Prohibiting ARNPs/APRNs and PAs from using the title 'doctor' restricts professional self-identification and speech in clinical settings, potentially undermining autonomy and professional identity—especially for those who earned a clinical doctorate (e.g., DNP, ScD) and use 'doctor' in academic or non-patient-facing roles. This constitutes a content-based restriction on professional speech without a demonstrated harm from current usage patterns.
Rights & LibertiesPeopleRef: Sec. 2(2)(b) and Sec. 3(2)(b)Healthcare employers (clinics, hospitals, health systems) must incur administrative costs to revise signage, name badges, email signatures, EHR fields, and training materials to comply with the new title restrictions—costs that disproportionately burden small-to-mid-sized clinics and rural providers with limited administrative staff.
Business & EmploymentPeopleRef: Sec. 2(2)(b), Sec. 3(2)(b), Sec. 4(5)The ban may reduce continuity of care and patient trust for patients who have established relationships with ARNPs/PAs who use 'doctor'—especially in rural and underserved areas where these providers are often the primary care clinicians. Patients may misinterpret the restriction as a signal that the provider is less qualified, even when the provider has a clinical doctorate.
HealthcarePeopleRef: Sec. 2(2)(b), Sec. 3(2)(b), Sec. 4(5)The law conflates academic credentials (e.g., DNP, ScD) with medical degrees (MD/DO), potentially devaluing advanced nursing and PA education and discouraging pursuit of clinical doctorates—despite evidence that DNP-prepared nurse practitioners deliver high-quality, cost-effective care with outcomes comparable to physicians.
EducationPeopleRef: Sec. 2(2)(b), Sec. 3(2)(b), Sec. 4(5)The sunset provision (June 30, 2027) for ARNPs/APRNs creates regulatory uncertainty, requiring repeated legislative review and potentially leading to inconsistent enforcement across licensing boards and health systems during the interim period.
Local GovernmentLean peopleRef: Sec. 5 (sunset clause)
Who Is Most Affected
ARNPs/APRNs and PAs who hold clinical doctorates (e.g., DNP, ScD) will be prohibited from using 'doctor' in clinical settings, potentially diminishing their professional identity and autonomy—especially those who have invested in advanced education and use the title consistently in academic or administrative roles.
Patients—especially older, rural, or low-literacy individuals—may benefit from clearer provider identification, but could also be confused or misled if they associate 'doctor' with higher qualification, potentially undermining trust in ARNPs/PAs who must now use alternative titles.
Small clinics, rural health centers, and community health organizations will face administrative burdens to revise signage, badges, and EHR fields—costs that are proportionally higher for smaller providers with limited staff and budgets.
Large health systems and hospital networks have the administrative infrastructure to absorb compliance costs more easily and may even benefit from standardized, risk-averse branding—though they face no material financial upside.
Medical and nursing schools may adjust curricula or orientation materials to clarify title usage expectations, but the bill has minimal direct impact on education—though it may discourage enrollment in clinical doctorate programs if perceived as devaluing the credential.